A-796260 is a synthetic cannabinoid (CB) that shows high selectivity for the CB2 receptor (Ki = 0.77 nM) over the CB1 receptor (Ki = 2,100 nM). It also shows efficacy in vivo in models of inflammatory, post-operative, neuropathic, and osteoarthritic pain, activities which are selectively blocked by CB2 receptor-selective antagonists. This product is intended for research and forensic uses.
A-796,260 is a synthetic cannabinoid that shows high selectivity towards CB2 receptor over the CB1 receptor. A-796,260 showed high efficacy in models of inflammatory, post-operative, neuropathic and OA pain in vivo.
